Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/ene.14383 http://scihub22266oqcxt.onion/10.1111/ene.14383 32503084!7300794!32503084     free     free     free       Eur+J+Neurol 2020 ; 27 (9): 1759-1761 Nephropedia Template TP {{tp|p=32503084|t=2020. Miller-Fisher syndrome after SARS-CoV-2 infection |pdf=|usr=}}{{32503084}} gab.com Text Miller-Fisher syndrome after SARS-CoV-2 infection JO: Eur J Neurol http://www.kidney.de/pget.php?&tw=1&pmid=32503084 #FOAvip INTRODUCTION: On March 11th, 2020, the WHO declared the SARS-Cov-2 pandemic. Syndromes have been detected in relation to COVID-19 such as encephalitis, acute necrotizing hemorrhagic encephalopathy and cerebrovascular complications. There are also cases of peripheral nervous system involvement. METHODS: Our case would be the 3rd patient with MFS associated with COVID-19 as far as we know. RESULTS: We present a 51 years old female diagnosed with MFS two weeks after COVID-19. RTPCR to SARS-CoV-2 was negative but IgG was positive. CONCLUSION: Most of the cases were mild or moderate with typical signs and symptoms. All were treated with IV immunoglobulin with good response in most cases. Despite the short evolution time of the cases surviving the current pandemic, the description of cases of post-infectious neurological syndromes suggests that this is probably not an infrequent complication in the subacute stage of Covid-19 disease. Twit Text FOAVip Miller-Fisher syndrome after SARS-CoV-2 infection ????Eur J Neurol http://www.kidney.de/pget.php?&tw=1&pmid=32503084 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32503084 #FOAvip English Wikipedia <ref>{{Cite pmid|32503084}}</ref> Miller-Fisher syndrome after SARS-CoV-2 infection #MMPMID32503084 Reyes-Bueno JA; Garcia-Trujillo L; Urbaneja P; Ciano-Petersen NL; Postigo-Pozo MJ; Martinez-Tomas C; Serrano-Castro PJ Eur J Neurol 2020[Sep]; 27 (9): 1759-1761 PMID32503084show ga INTRODUCTION: On March 11th, 2020, the WHO declared the SARS-Cov-2 pandemic. Syndromes have been detected in relation to COVID-19 such as encephalitis, acute necrotizing hemorrhagic encephalopathy and cerebrovascular complications. There are also cases of peripheral nervous system involvement. METHODS: Our case would be the 3rd patient with MFS associated with COVID-19 as far as we know. RESULTS: We present a 51 years old female diagnosed with MFS two weeks after COVID-19. RTPCR to SARS-CoV-2 was negative but IgG was positive. CONCLUSION: Most of the cases were mild or moderate with typical signs and symptoms. All were treated with IV immunoglobulin with good response in most cases. Despite the short evolution time of the cases surviving the current pandemic, the description of cases of post-infectious neurological syndromes suggests that this is probably not an infrequent complication in the subacute stage of Covid-19 disease. |COVID-19/*complications[MESH] |Female[MESH] |Humans[MESH] |Immunoglobulins, Intravenous[MESH] |Middle Aged[MESH] |Miller Fisher Syndrome/drug therapy/*etiology[MESH]Miller-Fisher syndrome after SARS-CoV-2 infection (epmc).pdf DeepDyve Pubget Overpricing